The organometallic complexes ([Ru(COD)(2-methylallyl)2] and [Ni(COD)2] (COD=1,5-cyclooctadiene) dissolved in imidazolium ionic liquids (ILs) undergo reduction and decomposition, respectively, to afford stable ruthenium and nickel metal(0) nanoparticles (Ru(0)-NPs and Ni(0)-NPs) in the absence of classical reducing agents. Depending on the case, the reduction/auto-decomposition is promoted by either the cation and/or anion of the neat imidazolium ILs.
No takes yet. Share an insight, caveat, or question.
Prechtl et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: